Home - Products - Others - Other Targets - Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)

Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)

CAS No. 93965-89-0

Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)( ——— )

Catalog No. M41195 CAS No. 93965-89-0

[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.
  • Description
    [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.
  • In Vitro
    Cell Proliferation Assay Cell Line:C6 rat glioblastoma cells Concentration:0.1 pM-10 nM Incubation Time:3 days Result:Induced a dose-dependent cell proliferation increase.
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VIP
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    93965-89-0
  • Formula Weight
    3476.09
  • Molecular Formula
    C157H252N44O43S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Waelbroeck M, et al. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology. 1985 Jun;116(6):2643-9.?
molnova catalog
related products